On one hand, the aggregate data shows that more than half of GLP-1 users (65 percent), regardless of gender, bracket multiple sizes, higher than the 30 percent of general consumers who do, according to a separate and earlier ReturnPro study
Supplementary information Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Determining when to stop depends on the specific medication, as they each stay in the body for different lengths of time
These are available specifically designed for insulin and comparable medications
Metabolically healthy obesity
Which GLP-1 is taken daily